Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome

Published:2017-06 Issue:6 Volume:130 Page:746.e1-746.e7
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Kasmari Allison J.,Welch Amy^ORCID,Liu Guodong,Leslie Doug,McGarrity Thomas,Riley Thomas

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?;El-Serag;Hepatology,2014

2. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice;Singal;Clin Gastroenterol Hepatol,2015

3. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience;Yuen;Hepatology,2000

4. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study;Davila;Gastroenterology,2004

5. Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience;Perumpail;Dig Dis Sci,2015

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin as adjuvant treatment in hepatitis C virus infections and associated complications;The American Journal of the Medical Sciences;2024-08

2. Ensemble learning enhances the precision of preliminary detection of primary hepatocellular carcinoma based on serological and demographic indices;Frontiers in Oncology;2024-06-17

3. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections;Journal of Cancer Metastasis and Treatment;2024-01-23

4. The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease;Discovery Medicine;2024

5. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?;Viruses;2023-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3